Dominique Morisano

“Getting Psychedelic-Assisted Psychotherapy Right: The Good, the Bad, and the Ugly”

Dr. Dominique Morisano, CPsych (she/her) is of Italian/Balto-Slavic descent and a dualCanadian/US citizen raised in rural Connecticut. She works as a clinical psychologist in private practice and is Adjunct Professor at the University of Toronto and University of Ottawa and engages in teaching, clinical practice, research, and consultation in North America and Europe. She has received training in psychedelic-assisted psychotherapies from many institutions, including the California Institute of Integral Studies (CIIS) Certificate in Psychedelic-Assisted Therapies and Research, and MAPS MDMA Therapy and Ketamine Training Center certificates. Since 2021, she also has been studying plant medicines and learning from Shipibo curanderos of ayahuasca medicine in the Peruvian Amazon, as well from as their apprentices.

She served in executive leadership at the psychedelic therapy company Field Trip Health until December 2021, and runs a trauma/addiction-focused private practice (New York/Ontario/Oregon), including Ketamine-Assisted Psychotherapy. She facilitates in Jamaica and the Netherlands with Beckley Retreats, and works as an Advisor/consultant for several companies and professionals in the psychedelic therapies space. She teaches/mentors at CIIS, the University of Ottawa, Naropa, Mind Foundation, Fluence, Journey Clinical, and Psychedelics Today’s Vital Program.
She is also co-Founder/Board Chair of the nonprofit Psychedelics R2R, which was behind the 2022 international psychedelics research conference “From Research to Reality: Global Summit on Psychedelic-Assisted Therapies and Medicine” (Toronto) and two recent special journal issues on psychedelic therapies in the Journal of Studies on Alcohol and Drugs and the International Journal of Mental Health and Addiction.  Website: drmorisano.com.